All properties in NCIT
Label | Id | Description |
---|---|---|
Chemical_Formula | NCIT_P350 | [A property representing a concise expression about the atoms that constitute a particular chemical compound.] |
Chemical_Or_Drug_Affects_Abnormal_Cell | NCIT_R150 | [A role used to establish the relationship between a therapeutic agent and an abnormal cell type associated with a disease condition. By pointing to abnormal cells, the therapeutic target of a drug can be more clearly conveyed. The domain and range for this role are 'Drug, Food, Chemical or Biomedical Material' and 'Abnormal Cell', respectively.] |
Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue | NCIT_R72 | [A role used to represent the intended target cells for a chemical or drug. This does not include unintended target cells or tissues that are associated with side effects or toxicity of the chemical or drug. The domain and range for this role are 'Drug, Food, Chemical or Biomedical Material' and 'Anatomic Structure, System, or Substance', respectively.] |
Chemical_Or_Drug_Affects_Gene_Product | NCIT_R146 | [A role used to assert that a gene product is the target of a therapeutic agent. The role implies a direct interaction between the product and the therapeutic agent but it does not specify the type of association (e.g., involvement, interference, inhibition or cleavage). The domain and range for this role are 'Drug, Food, Chemical or Biomedical Material' and 'Gene Product', respectively.] |
Chemical_Or_Drug_Has_Mechanism_Of_Action | NCIT_R124 | [A role used to imply the interaction or binding of an active ingredient of a drug/chemical agent at the molecular level with its target. When possible, the role value should reflect the direct alteration of function of a target molecule or complex. The domain and range for this role are 'Drug, Food, Chemical or Biomedical Material' and 'Biological Process', respectively.] |
Chemical_Or_Drug_Has_Physiologic_Effect | NCIT_R125 | [A role used to describe the primary detectable alterations of subcellular, cellular, tissue, or organ functions that directly result from alteration of function of a target biological molecule or complex caused by interaction of a therapeutic agent with a target molecule or complex. The domain and range for this role are 'Drug, Food, Chemical or Biomedical Material' and 'Biological Process', respectively.] |
Chemical_Or_Drug_Is_Metabolized_By_Enzyme | NCIT_R122 | [A role used to specify that an enzyme is directly responsible for metabolizing a chemical or drug into an active form, inactive form, or both. The domain and range for this role are 'Drug, Food, Chemical or Biomedical Material' and 'Gene Product', respectively.] |
Chemical_Or_Drug_Plays_Role_In_Biological_Process | NCIT_R66 | [A role used to assert that an active ingredient of a drug or chemical agent influences a biological process. The role implies a direct association with a target biological molecule or complex involved in the process. The domain and range for this role are 'Drug, Food, Chemical or Biomedical Material' and 'Biological Process', respectively.] |
Chemotherapy_Regimen_Has_Component | NCIT_R123 | [A role used to specify the component agents which are used in a particular chemotherapy regimen or agent combination. The domain and the range for this role are 'Chemotherapy Regimen or Agent Combination' and 'Drug, Food, Chemical or Biomedical Material', respectively.] |
Concept_In_Subset | NCIT_A8 | [An association that connects the concept defining a particular terminology subset with concepts that belong to this subset.] |
Concept_Status | NCIT_P310 | [A property used to indicate the standing of a concept in relation to currently accepted classifications and concepts. In NCI Thesaurus concept status subtype indicates concepts with unusual and problematic characteristics that should be evaluated by people and/or programs before those concept are used.] |
Conceptual_Part_Of | NCIT_R27 | [A role used to indicate that a conceptual entity is a sub-entity of another conceptual entity. Both the domain and the range for this role are 'Conceptual Entity'.] |
Contributing_Source | NCIT_P322 | [A property is used to indicate when a non-EVS entity has contributed to, and has a stake in, a concept. This is used where such entities, within or outside NCI, have indicated the need to be able to track their own concepts. A single concept can have multiple instances of this property if multiple entities have such a defined stake.] |
Cytogenetic_Abnormality_Involves_Chromosome | NCIT_R173 | [A role used to assert a direct relationship between a cytogenetic abnormality and a chromosome. The domain and range for this role are 'Cytogenetic Abnormality' and 'Chromosome', respectively. The range for this role excludes chromosomal bands and physical locations.] |
DEFINITION | NCIT_P97 | [A property representing the English language definitions of what NCI means by the concept. They may also include information about the definition's source and attribution in a form that can easily be interpreted by software.] |
Definition_Review_Date | NCIT_Definition_Review_Date | |
Definition_Reviewer_Name | NCIT_Definition_Reviewer_Name | |
DesignNote | NCIT_P98 | [A property representing notations made by NCI vocabulary curators. They are intended to provide supplemental, unstructured information to the user or additional insight about the concept.] |
Disease_Excludes_Abnormal_Cell | NCIT_R139 | [A specializing role which may be used to override Disease_Has_Abnormal_Cell. The domain and the range for this role are 'Disease, Disorder or Finding' and 'Abnormal Cell', respectively.] |
Disease_Excludes_Cytogenetic_Abnormality | NCIT_R141 | [A specializing role which may be used to override Disease_Has_Cytogenetic_Abnormality. The domain and the range for this role are 'Disease, Disorder or Finding' and 'Molecular Abnormality', respectively.] |